Cargando…
Amyloid‐β PET in Alzheimer's disease: A systematic review and Bayesian meta‐analysis
BACKGROUND: In recent years, longitudinal studies of Alzheimer's disease (AD) have been successively concluded. Our aim is to determine the efficacy of amyloid‐β (Aβ) PET in diagnosing AD and early prediction of mild cognitive impairment (MCI) converting to AD. By pooling studies from different...
Autores principales: | Ruan, Dan, Sun, Long |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847612/ https://www.ncbi.nlm.nih.gov/pubmed/36573329 http://dx.doi.org/10.1002/brb3.2850 |
Ejemplares similares
-
Diagnostic accuracy of (18)F amyloid PET tracers for the diagnosis of Alzheimer’s disease: a systematic review and meta-analysis
por: Morris, Elizabeth, et al.
Publicado: (2015) -
Efficacy and safety of anti‐amyloid‐β immunotherapy for Alzheimer's disease: a systematic review and network meta‐analysis
por: Mo, Jia‐Jie, et al.
Publicado: (2017) -
Amyloid PET imaging: applications beyond Alzheimer’s disease
por: Catafau, Ana M., et al.
Publicado: (2015) -
β-Amyloid Degradation and Alzheimer's Disease
por: Wang, Deng-Shun, et al.
Publicado: (2006) -
Mitochondria, Amyloid β, and Alzheimer's Disease
por: Readnower, Ryan D., et al.
Publicado: (2011)